Pep is a self-guided chronic pain management app providing neuroscience-based exercises and mindfulness tools on iOS and Android.
The App DNA
What makes this app unique?
Users hire Pep to manage chronic symptoms through non-pharmacological techniques, seeking a supportive digital companion that validates their pain experience while providing actionable recovery steps.
For Individuals suffering from chronic pain who are seeking non-pharmacological, science-backed self-management tools.
What does it look like?
Key features
Daily interactive exercises based on pain reprocessing therapy to retrain brain pain processing.
Guided exercises for immediate grounding during acute pain spikes.
Program adjusts content based on user progress to tailor the healing journey.
How much does it cost?
Freemium model utilizing a free trial to lower the barrier to entry for a self-guided medical-adjacent program.
Velocity
Dormant developmentplatform expansionShow more...
Pep: Chronic Pain Relief has been inactive for 324 days, falling well outside the threshold for active development. The last recorded update was a platform expansion to international markets in September 2025. Given the lack of any releases in the last 10 months, the app is currently classified as a zombie project.
Who built it?
User Sentiment
What do users think recently?
Fresh user feedback skews thrilled. Users appreciate pain tracking and mindfulness exercises provide tangible relief for users managing chronic physical discomfort daily and empathetic messaging and supportive tone validate the lived experience of users suffering from chronic conditions.
How are ratings & reviews evolving?
What users say, by theme
- Pain tracking and mindfulness exercises provide tangible relief for users managing chronic physical discomfort daily
- Empathetic messaging and supportive tone validate the lived experience of users suffering from chronic conditions
- Science-based methodology and educational content inspire healthier thinking patterns for users seeking long-term recovery
7 of 7 recent reviews analyzed · limited sample · Thrilled overall
Read the full review analysisCompetition
Competitive landscape for Pep: Chronic Pain Relief
How's the Health & Fitness market?
Pep occupies a niche in the Health & Fitness category, relying on clinical research credibility rather than high-frequency chart rank to attract users. The lack of Android rating volume compared to the iOS 5-star rating suggests an uneven distribution strategy that limits total addressable market reach.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Pep: Chronic Pain Relief
Where is it heading?
The chronic pain management market is shifting toward high-frequency content updates and community-driven support, leaving static apps exposed to churn. Pep's current maintenance-mode posture risks losing its clinical credibility advantage if it fails to provide fresh recovery content to its user base.
- The 10-month update silence suggests the app is in maintenance-mode, which reduces the perceived value of the subscription for long-term recovery journeys.
- Uniformly positive reviews indicate the core neuroscience methodology remains effective, providing a stable foundation for a future feature-expansion cycle.
The SWOT
- Evidence-based methodology anchored in research from Stanford and Mayo Clinic builds clinical credibility.
- Empathetic UX design validates user pain, increasing session stickiness for chronic condition management.
- Untapped B2B distribution through partnerships with pain clinics and physical therapy networks.
- Wearable integration could automate movement reminders, increasing the utility of the current exercise library.
Next best moves
Ship content-refresh sprint because the 10-month update gap risks churn to more active competitors → increase long-term retention
+ 1 more prioritized moveThe counter-intuitive read
The 10-month update silence is a strategic vulnerability…
Read the full takeSince the last report: The analysis now incorporates specific clinical credibility markers and identifies a critical lack of Android platform traction as a primary weakness.
Bottom line
Pep delivers high-value neuroscience content that resonates with chronic pain patients, but the 10-month development gap signals a lack of active investment, so the PM must prioritize a content-refresh sprint to prevent churn to more active competitors.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated